LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 PI103
0.12
uM
LJP6
 0.7154 0.0541 0.5362 0.0613
SK-BR-3 PLX-4720
0.12
uM
LJP5
 1.0209 0.0065 1.0344 0.0102
SK-BR-3 QL-X-138
0.12
uM
LJP6
 0.6254 0.0253 0.3751 0.0567
SK-BR-3 QL-XII-47
0.12
uM
LJP6
 0.5831 0.0519 0.3130 0.0653
SK-BR-3 Radicicol
0.12
uM
LJP5
 0.4578 0.0182 0.0992 0.0333
SK-BR-3 Radicicol
0.12
uM
LJP6
 0.4300 0.0243 0.0522 0.0515
SK-BR-3 Seliciclib
0.12
uM
LJP5
 1.0460 0.0234 1.0794 0.0397
SK-BR-3 Ruxolitinib
0.12
uM
LJP5
 0.9556 0.0349 0.9243 0.0576
SK-BR-3 XL147
0.12
uM
LJP5
 1.1229 0.0326 1.2002 0.0495
SK-BR-3 Saracatinib
0.12
uM
LJP6
 1.0584 0.0427 1.0922 0.0717
SK-BR-3 Selumetinib
0.12
uM
LJP6
 1.0040 0.0109 1.0046 0.0179
SK-BR-3 Sirolimus
0.12
uM
LJP6
 0.6476 0.0072 0.4139 0.0228
SK-BR-3 Sorafenib
0.12
uM
LJP6
 0.9471 0.0295 0.9139 0.0493
SK-BR-3 SU11274
0.12
uM
LJP5
 1.0735 0.0377 1.1264 0.0633
SK-BR-3 Fedratinib
0.12
uM
LJP5
 1.0176 0.0087 1.0306 0.0149
SK-BR-3 TGX221
0.12
uM
LJP5
 0.8783 0.0153 0.7979 0.0255
SK-BR-3 Torin1
0.12
uM
LJP6
 0.3914 0.0209 -0.0178 0.0921
SK-BR-3 Torin2
0.12
uM
LJP5
 0.3267 0.0116 -0.1217 0.0651
SK-BR-3 Tozasertib
0.12
uM
LJP5
 0.3346 0.0126 -0.1068 0.0453
SK-BR-3 Trametinib
0.12
uM
LJP5
 0.7597 0.0068 0.5984 0.0330
SK-BR-3 TWS119
0.12
uM
LJP5
 1.0170 0.0228 1.0238 0.0358
SK-BR-3 Vemurafenib
0.12
uM
LJP5
 1.0432 0.0163 1.0718 0.0272
SK-BR-3 Withaferin A
0.12
uM
LJP5
 0.9878 0.0415 0.9735 0.0661
SK-BR-3 Withaferin A
0.12
uM
LJP6
 0.8794 0.0102 0.7998 0.0163
SK-BR-3 WYE-125132
0.12
uM
LJP6
 0.3994 0.0120 -0.0014 0.0663